[1] 中华人民共和国卫生部.中国出生缺陷防治报告(2012)[R/OL].(2012-09-12)[2017-02-10].http://www.moh.gov.cn/wsb/pxwfb/201209/55840.shtml. Ministry of Health of the People's Republic of China. China report on prevention and treatment of birth defects (2012)[R/OL].(2012-09-12)[2017-02-10].http://www.moh.gov.cn/wsb/pxwfb/201209/55840.shtml. (in Chinese)
[2] CHRISTIANSON A, HOWSON C P, MODELL B. Global report on birth defects[M]. White Plains. NY:March of Dimes,2006.
[3] 成胜权.出生缺陷及常见出生缺陷早期诊断和干预[J/CD].发育医学电子杂志,2015,3(1):1-7,13. CHENG Shengquan. Early diagnosis and intervention in birth defects and common birth defect[J/CD].Journal Developmental Medicine (Electronic Version),2015,3(1):1-7,13.(in Chinese)
[4] 王心,尚丽新.出生缺陷的预防[J].人民军医,2016,59(1):90-93. WANG Xin, SHANG Lixin. Prevention of birth defects[J]. People's Military Surgeon,2016,59(1):90-93.(in Chinese)
[5] SPEICHER M R, CARTER N P. The new cytogenetics:blurring the boundaries with molecular biology[J]. Nat Rev Genet,2005,6(10):782-792.
[6] HARPER J C, DE DIE-SMULDERS C, GOOSSENS V, et al. ESHRE PGD consortium data collection Ⅶ:cycles from January to December 2004 with pregnancy follow-up to October 2005[J]. Hum Reprod,2008,23(4):741-755.
[7] MULLIS K, FALOONA F, SCHARF S, et al. Specific enzymatic amplification of DNA in vitro:the polymerase chain reaction. 1986[J]. Biotechnology,1992,24:17-27.
[8] SANGER F. Determination of nucleotide sequences in DNA[J]. Biosci Rep,2004,24(4-5):237-253.
[9] SAIKI R K, GELFAND D H, STOFFEL S, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase[J]. Science,1988,239(4839):487-491.
[10] WESSENDORF S, FRITZ B, WROBEL G, et al. Automated screening for genomic imbalances using matrix-based comparative genomic hybridization[J]. Lab Invest,2002,82(1):47-60.
[11] HEISKANEN M A, BITTNER M L, CHEN Y, et al. Detection of gene amplification by genomic hybridization to cDNA microarrays[J]. Cancer Res,2000,60(4):799-802.
[12] BRADY P D, VERMEESCH J R. Genomic microarrays:a technology overview[J]. Prenat Diagn,2012,32(4):336-343.
[13] ACOG Committee Opinion No.446:array comparative genomic hybridization in prenatal diagnosis[J]. Obstet Gynecol,2009,114(5):1161-1163.
[14] TAN Y Q, TAN K, ZHANG S P, et al. Single-nucleotide polymorphism microarray-based preimplantation genetic diagnosis is likely to improve the clinical outcome for translocation carriers[J]. Hum Reprod,2013,28(9):2581-2592.
[15] HANDYSIDE A H, HARTON G L, MARIANI B, et al. Karyomapping:a universal method for genome wide analysis of genetic disease based on mapping crossovers between parental haplotypes[J]. J Med Genet,2010,47(10):651-658.
[16] NATESAN S A, BLADON A J, COSKUN S, et al. Genome-wide karyomapping accurately identifies the inheritance of single-gene defects in human preimplantation embryos in vitro[J]. Genet Med,2014,16(11):838-845.
[17] YUAN Y, JIANG F, HUA S, et al. Feasibility study of semiconductor sequencing for noninvasive prenatal detection of fetal aneuploidy[J]. Clin Chem,2013,59(5):846-849.
[18] NEVELING K, FEENSTRA I, GILISSEN C, et al. A post-hoc comparison of the utility of sanger sequencing and exome sequencing for the diagnosis of heterogeneous diseases[J]. Hum Mutat,2013,34(12):1721-1726.
[19] LO Y M, CORBETTA N, CHAMBERLAIN P F, et al. Presence of fetal DNA in maternal plasma and serum[J]. Lancet,1997,350(9076):485-487.
[20] CHIU R W, CHAN K C, GAO Y, et al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma[J]. Proc Natl Acad Sci U S A,2008,105(51):20458-20463.
[21] FAN H C, BLUMENFELD Y J, CHITKARA U, et al. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood[J]. Proc Natl Acad Sci U S A,2008,105(42):16266-16271.
[22] PETERS D, CHU T, YATSENKO S A, et al. Noninvasive prenatal diagnosis of a fetal microdeletion syndrome[J]. N Engl J Med,2011,365(19):1847-1848.
[23] EHRICH M, DECIU C, ZWIEFELHOFER T, et al. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood:a study in a clinical setting[J]. Am J Obstet Gynecol,2011,204(3):205.e1-11.
[24] PALOMAKI G E, KLOZA E M, LAMBERT-MESSERLIAN G M, et al. DNA sequencing of maternal plasma to detect Down syndrome:an international clinical validation study[J]. Genet Med,2011,13(11):913-920.
[25] CHIU R W, AKOLEKAR R, ZHENG Y W, et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing:large scale validity study[J]. BMJ,2011,342:c7401.
[26] GONZÁLEZ-GONZÁLEZ M C, TRUJILLO M J, RODRÍGUEZ DE ALBA M, et al. Huntington disease-unaffected fetus diagnosed from maternal plasma using QF-PCR[J]. Prenat Diagn,2003,23(3):232-234.
[27] GONZÁLEZ-GONZÁLEZ M C, GARCÍA-HOYOS M, TRUJILLO M J, et al. Prenatal detection of a cystic fibrosis mutation in fetal DNA from maternal plasma[J]. Prenat Diagn,2002,22(10):946-948.
[28] LV W, WEI X, GUOR, et al. Noninvasive prenatal testing for wilson disease by use of circulating single-molecule amplification and resequencing technology (cSMART)[J]. Clin Chem,2015,61(1):172-181.
[29] RENWICK P, TRUSSLER J, LASHWOOD A, et al. Preimplantation genetic haplotyping:127 diagnostic cycles demonstrating a robust, efficient alternative to direct mutation testing on single cells[J]. Reprod Biomed Online,2010,20(4):470-476.
[30] GUTIÉRREZ-MATEO C, SÁNCHEZ-GARCÍA J F, FISCHER J, et al. Preimplantation genetic diagnosis of single-gene disorders:experience with more than 200 cycles conducted by a reference laboratory in the United States[J]. Fertil Steril,2009,92(5):1544-1556.
[31] 谢平原,胡亮,林戈.二代测序技术在植入前遗传学诊断中的应用[J].中国实用妇科与产科杂志,2016,3(3):247-251,32. XIE Pingyuan, HU Liang, LIN Ge. Application of next-generation sequencing in preimplantation genetic diagnosis[J]. Chinese Journal of Practical Gynecology and Obstetrics,2016,3(3):247-251,32.(in Chinese)